Clinical Features of Bacteremia due to <i>Campylobacter jejuni</i>
-
- Mori Takehiko
- Center for Infectious Diseases and Infection Control, Keio University School of Medicine, Japan Division of Hematology, Keio University School of Medicine, Japan
-
- Hasegawa Naoki
- Center for Infectious Diseases and Infection Control, Keio University School of Medicine, Japan
-
- Sugita Kayoko
- Center for Infectious Diseases and Infection Control, Keio University School of Medicine, Japan
-
- Shinjoh Masayoshi
- Center for Infectious Diseases and Infection Control, Keio University School of Medicine, Japan
-
- Nakamoto Nobuhiro
- Division of Gastroenterology, Keio University School of Medicine, Japan
-
- Shimizu Takayuki
- Division of Hematology, Keio University School of Medicine, Japan
-
- Hori Shingo
- Department of Emergency and Critical Care Medicine, Keio University School of Medicine, Japan
-
- Iketani Osamu
- Center for Infectious Diseases and Infection Control, Keio University School of Medicine, Japan
-
- Fujiwara Hiroshi
- Center for Infectious Diseases and Infection Control, Keio University School of Medicine, Japan
-
- Takano Yaoko
- Center for Infectious Diseases and Infection Control, Keio University School of Medicine, Japan
-
- Iwata Satoshi
- Center for Infectious Diseases and Infection Control, Keio University School of Medicine, Japan
この論文をさがす
抄録
Objective The clinical features of bacteremia due to Campylobacter jejuni (C. jejuni) have yet to be fully elucidated.<br> Methods and Results The cases of C. jejuni bacteremia were retrospectively reviewed during a twelve-year period in a single institute. C. jejuni was identified in 7 patients through blood cultures, and disease onset occurred between June and October. Except for 2 previously healthy individuals, 5 patients had underlying diseases (chronic liver diseases, n=3; hematological malignancies, n=2). All patients were febrile, but 2 patients did not present with gastrointestinal symptoms. C. jejuni isolates were susceptible to gentamicin and macrolides, but about half of them were resistant to fluoroquinolones. Disease outcomes were favorable, and no deaths related to C. jejuni bacteremia were observed.<br> Conclusion These results suggest that C. jejuni bacteremia could occur primarily or secondarily to gastroenteritis with a seasonal peak and that prognosis would be favorable regardless of the underlying diseases.<br>
収録刊行物
-
- Internal Medicine
-
Internal Medicine 53 (17), 1941-1944, 2014
一般社団法人 日本内科学会